Stoke Therapeutics (STOK) EPS (Basic) (2018 - 2026)
Stoke Therapeutics' quarterly EPS (Basic) came in at -$0.79 in Q1 2026, down 140.51% year-on-year from $1.95 in Q1 2025, and up 21.0% quarter-over-quarter from -$1.0 in Q4 2025.
Stoke Therapeutics has reported EPS (Basic) for 9 years, with the latest figure at -$0.79 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) fell 140.51% year-over-year to -$0.79; the trailing twelve-month figure through Mar 2026 stood at -$2.84 (down 434.12% YoY), and the FY2025 full-year result was -$0.12, up 92.73% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.79, up from -$1.0 in the prior quarter.
- The five-year high for EPS (Basic) was $1.95 in Q1 2025, with the low at -$1.0 in Q4 2025.
- Average EPS (Basic) over 5 years is -$0.44, with a median of -$0.6 recorded in 2023.
- Peak annual rise in EPS (Basic) reached 442.11% in 2025, while the deepest fall reached 488.24% in 2025.
- Tracing STOK's EPS (Basic) over 5 years: stood at -$0.65 in 2022, then increased by 7.69% to -$0.6 in 2023, then soared by 71.67% to -$0.17 in 2024, then plunged by 488.24% to -$1.0 in 2025, then advanced by 21.0% to -$0.79 in 2026.
- The last three EPS (Basic) figures came in at -$0.79 (Q1 2026), -$1.0 (Q4 2025), and -$0.65 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.06 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 0.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 4.06 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 6.99 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.55 |
| 10 | Stoke Therapeutics | 1.92 Bn | 1.92 Bn | - | -0.79 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.79 |
| Dec 31, 2025 | -1.00 |
| Sep 30, 2025 | -0.65 |
| Jun 30, 2025 | -0.40 |
| Mar 31, 2025 | 1.95 |
| Dec 31, 2024 | -0.17 |
| Sep 30, 2024 | -0.47 |
| Jun 30, 2024 | -0.46 |
| Mar 31, 2024 | -0.57 |
| Dec 31, 2023 | -0.60 |
| Sep 30, 2023 | -0.55 |
| Jun 30, 2023 | -0.69 |
| Mar 31, 2023 | -0.53 |
| Dec 31, 2022 | -0.65 |
| Sep 30, 2022 | -0.66 |
| Jun 30, 2022 | -0.63 |
| Mar 31, 2022 | -0.66 |
| Dec 31, 2021 | -0.67 |
| Sep 30, 2021 | -0.61 |
| Jun 30, 2021 | -0.60 |
| Mar 31, 2021 | -0.46 |
| Dec 31, 2020 | -0.42 |
| Sep 30, 2020 | -0.41 |
| Jun 30, 2020 | -0.39 |
| Mar 31, 2020 | -0.34 |
| Dec 31, 2019 | -0.31 |
| Sep 30, 2019 | -0.26 |
| Jun 30, 2019 | -1.54 |
| Mar 31, 2019 | -6.89 |
| Dec 31, 2018 | -6.05 |
| Sep 30, 2018 | -4.75 |
| Jun 30, 2018 | -4.36 |